Skip to main content
. 2022 Jan 11;77(7):2090–2103. doi: 10.1111/all.15206

FIGURE 2.

FIGURE 2

Distribution of serological testing results in patients with and without previous COVID‐19. IgG or pan‐Ig responses against the nucleoprotein (N), the receptor‐binding domain of the SARS‐CoV‐2 spike glycoprotein (RBD), the domain 1 or 2 of the SARS‐CoV‐2 spike glycoprotein (S1/S2), and the extended RBD domain are shown. Consecutive health‐care workers and inpatients with suspected or possible previous COVID‐19 were prospectively included (= 3658; prevalence 5.3%)